These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7206293)

  • 1. [Changes in HDL-cholesterol in hepatobiliary disorders (author's transl)].
    Yamashita S; Yamamoto S; Hino K; Ohashi K; Hirano Y
    Nihon Shokakibyo Gakkai Zasshi; 1980 Dec; 77(12):1984. PubMed ID: 7206293
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on high density lipoproteins in hepatobiliary diseases (author's transl)].
    Yamashita S
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):249-58. PubMed ID: 7098112
    [No Abstract]   [Full Text] [Related]  

  • 3. [HDL-cholesterol in the appearance of mid-beta lipoprotein band (author's transl)].
    Ikeda H; Maeda J
    Rinsho Byori; 1981 Nov; 29(11):1079-84. PubMed ID: 7334660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes of HDL levels determined by cholesterol and apoproteins (author's transl)].
    Koga S; Yamanaga Y; Shono T; Fujii S
    Rinsho Byori; 1981 Feb; 29(2):135-8. PubMed ID: 7230531
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the cholesterol composition of high-density lipoprotein in chronic liver diseases (author's transl)].
    Takagi Y
    Nihon Shokakibyo Gakkai Zasshi; 1980 Sep; 77(9):1362-8. PubMed ID: 7441912
    [No Abstract]   [Full Text] [Related]  

  • 6. [HDL-cholesterol in hepatobiliary diseases].
    Masana L; Masdéu S; Nubiola AR; Ras MR; Schwartz S; Rubies-Prat J; Bacardi R
    Rev Esp Enferm Apar Dig; 1981 Oct; 60(4):367-72. PubMed ID: 7330406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum lipids and serum lipoproteins in liver diseases (author's transl)].
    Greiner S; Wienbeck M; Englhardt A
    Med Klin; 1975 Feb; 70(6):231-41. PubMed ID: 164614
    [No Abstract]   [Full Text] [Related]  

  • 8. High-density lipoprotein cholesterol and phospholipids, and apoprotein A in serum of patients with liver disease.
    Rubiés-Prat J; Masdeu S; Nubiola AR; Chacón P; Holguera C; Masana L
    Clin Chem; 1982 Mar; 28(3):525-7. PubMed ID: 7067098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on HDL-cholesterol level in various liver diseases (author' transl)].
    Okamoto Y; Matsuoka Y; Kubota C; Umegaki K; Tsujii T
    Rinsho Byori; 1981 Nov; 29(11):1090-4. PubMed ID: 7334662
    [No Abstract]   [Full Text] [Related]  

  • 10. [Abnormal serum lipoproteins in cholestatic viral hepatitis (author's transl)].
    Picard J; Veissiere D; Bertrand F
    Clin Chim Acta; 1974 Feb; 51(1):5-12. PubMed ID: 4362760
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid and lipoprotein abnormalities in liver disease: the possible role of lecithin: cholesterol acyltransferase deficiency.
    McIntyre N; Calandra S; Pearson AJ
    Scand J Clin Lab Invest Suppl; 1974; 137():115-20. PubMed ID: 4367610
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma lipoproteins in liver disease.
    Agorastos J; Boswell C; Harry DS; McIntyre N
    Biochem Soc Trans; 1976; 4(4):593-6. PubMed ID: 187484
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of nicomol on HDL cholesterol level.
    Watanabe M; Taketa K; Nagashima H; Yamamoto Y
    Acta Med Okayama; 1979 Aug; 33(4):323-6. PubMed ID: 227232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL: total cholesterol & HDL2:HDL3 cholesterol ratios in liver diseases.
    Vadivelu N; Ramakrishnan S
    Indian J Med Res; 1986 Jan; 83():46-52. PubMed ID: 3699868
    [No Abstract]   [Full Text] [Related]  

  • 15. [HDL-cholesterol in cerebrovascular disease (author's transl)].
    Murai A; Miyahara T; Udaka F
    Rinsho Byori; 1981 Nov; 29(11):1095-100. PubMed ID: 7334663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Abnormal lipid metabolism in clinical and experimental cholestasis (author's transl)].
    Muto Y; Ando T
    Nihon Naika Gakkai Zasshi; 1980 Oct; 69(10):1256-60. PubMed ID: 7462756
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in high density lipoproteins in patients with hepatobiliary diseases. Levels and lipid composition of HDL2 and HDL3 and LCAT reaction.
    Kajiyama G; Takata K; Horiuchi I; Nakagawa M; Yamamoto M; Miyoshi A
    Gastroenterol Jpn; 1983 Apr; 18(2):98-108. PubMed ID: 6852443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in cholestasis of pregnancy.
    Johnson P; Samsioe G; Gustafson A
    Acta Obstet Gynecol Scand; 1975; 54(2):105-11. PubMed ID: 166548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of weight change on HDL cholesterol (author's transl)].
    Suyama Y; Shibata H; Matsuzaki T; Kumagai S
    Nihon Ronen Igakkai Zasshi; 1982 Jan; 19(1):1-7. PubMed ID: 7069933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.